MINOMYCIN 50 minocycline 50mg (as hydrochloride) tablet blister pack Australia - englanti - Department of Health (Therapeutic Goods Administration)

minomycin 50 minocycline 50mg (as hydrochloride) tablet blister pack

aspen pharma pty ltd - minocycline hydrochloride dihydrate, quantity: 53.985 mg (equivalent: minocycline, qty 50 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; sodium starch glycollate; povidone; sorbitol; microcrystalline cellulose; stearic acid; magnesium stearate; titanium dioxide; hypromellose; sunset yellow fcf; quinoline yellow; light liquid paraffin; sodium lauryl sulfate - indications as at 12 november 2003 : minocycline may be used for the treatment of infections caused by any of the following organisms provided that they have been shown by bacteriological testing to be susceptible to minocycline: escherichia coli, enterobacter aerogenes, haemophilus influenzae, klebsiella and proteus. it may also be used in the treatment of infections due to streptococcus pyogenes (group a beta-haemolytic) and streptococcus faecalis but because a large proportion of these organisms are resistant to tetracyclines, minocycline should be used only if the orgaisms have been shown to be definitely sensitive. tetracyclines, including minocycline, are not the drugs of choice in the treatment of staphylococcal infections. minocycline may be considered for the treatment of such infections only if other suitable agents are not available and the organism has been shown to be sensitive to minocycline. minocycline may be used in the treatment of tetracycline-resistant acne.